Read More Healthcare Industry News Why Oxford BioDynamics (AIM: OBD) needs cash by August despite good news Oxford BioDynamics just posted its best test order growth yet, hired a top genomics CEO, and still needs cash by August. The gap says everything. bySrinathJuly 6, 2026